{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:11:20Z","timestamp":1790871080890,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["31570913"],"award-info":[{"award-number":["31570913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["3137088"],"award-info":[{"award-number":["3137088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science Foundation of Hubei province","award":["2017CFB622"],"award-info":[{"award-number":["2017CFB622"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.molimm.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T00:05:48Z","timestamp":1526688348000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Fas\/FasL interaction mediates imbalanced cytokine\/cytotoxicity responses of iNKT cells against Jurkat cells"],"prefix":"10.1016","volume":"99","author":[{"given":"Rui","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2018.05.011_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.1841","article-title":"Raising the NKT cell family","volume":"11","author":"Godfrey","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0020","unstructured":"M. Nieda, A. Okai M Fau - Tazbirkova, H. Tazbirkova A Fau - Lin, A. Lin H Fau - Yamaura, K. Yamaura A Fau - Ide, R. Ide K Fau - Abraham, T. Abraham R Fau - Juji, D.J. Juji T Fau - Macfarlane, A.J. Macfarlane Dj Fau - Nicol, A.J. Nicol, Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity, DOI."},{"key":"10.1016\/j.molimm.2018.05.011_bib0025","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1073\/pnas.95.10.5690","article-title":"Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells","volume":"95","author":"Kawano","year":"1998","journal-title":"Proc. Natl. Acad Sci U. S. A."},{"key":"10.1016\/j.molimm.2018.05.011_bib0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2567.2000.00952.x","article-title":"Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells","volume":"99","author":"Nicol","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2018.05.011_bib0035","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.1001018","article-title":"Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95\/CD178-dependent and is correlated with antigenic potency","volume":"185","author":"Wingender","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0040","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molimm.2018.05.011_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008646","article-title":"iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells","volume":"5","author":"Bellone","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.molimm.2018.05.011_bib0050","first-page":"82","article-title":"NKT cell responses to B cell lymphoma","volume":"2","author":"Li","year":"2014","journal-title":"Med. Sci."},{"key":"10.1016\/j.molimm.2018.05.011_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-3083.2011.02607.x","article-title":"Role of natural killer T cells in the mouse colitis-associated colon cancer model","volume":"75","author":"Yoshioka","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/2326-6066.CIR-15-0062","article-title":"The regulatory role of invariant NKT cells in tumor immunity","volume":"3","author":"McEwen-Smith","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molimm.2018.05.011_bib0065","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/1078-0432.CCR-04-1453","article-title":"A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2018.05.011_bib0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00262-007-0373-5","article-title":"Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer","volume":"57","author":"Uchida","year":"2008","journal-title":"Cancer Immunol. Immunother. : CII"},{"key":"10.1016\/j.molimm.2018.05.011_bib0075","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20042592","article-title":"Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients","volume":"201","author":"Chang","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2018.05.011_bib0080","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1158\/1078-0432.CCR-10-3105","article-title":"Comparison of clinical and immunological effects of intravenous and intradermal administration of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells","volume":"17","author":"Nicol","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2018.05.011_bib0085","unstructured":"K. Haraguchi, F. Takahashi T Fau - Nakahara, A. Nakahara F Fau - Matsumoto, M. Matsumoto A Fau - Kurokawa, S. Kurokawa M Fau - Ogawa, H. Ogawa S Fau - Oda, H. Oda H Fau - Hirai, S. Hirai H Fau - Chiba, S. Chiba, CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells, DOI."},{"key":"10.1016\/j.molimm.2018.05.011_bib0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1073\/pnas.0408288102","article-title":"Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion","volume":"102","author":"Schmieg","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2018.05.011_bib0095","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.4049\/jimmunol.166.10.6012","article-title":"Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways","volume":"166","author":"Hayakawa","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0100","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4049\/jimmunol.178.5.2853","article-title":"Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice","volume":"178","author":"Shimizu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2326-6066.CIR-13-0104","article-title":"iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo","volume":"2","author":"Bassiri","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molimm.2018.05.011_bib0110","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/ijc.21764","article-title":"Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo","volume":"118","author":"Renukaradhya","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molimm.2018.05.011_bib0115","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.176.3.1421","article-title":"A cell-type specific CD1d expression program modulates invariant NKT cell development and function","volume":"176","author":"Zimmer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0120","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1543::AID-IMMU1543>3.0.CO;2-R","article-title":"Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions","volume":"29","author":"Taams","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0125","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.tp.0000288231.97880.bd","article-title":"Peptide-dependent inhibition of alloreactive T-cell response by soluble divalent HLA-A2\/IgG molecule in vitro","volume":"84","author":"Weng","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.molimm.2018.05.011_bib0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nprot.2007.515","article-title":"Methods for detection, isolation and culture of mouse and human invariant NKT cells","volume":"3","author":"Watarai","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molimm.2018.05.011_bib0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00005-015-0333-2","article-title":"A targeted multiple antigenic peptide vaccine augments the immune response to self TGF-beta1 and suppresses ongoing hepatic fibrosis","volume":"63","author":"Li","year":"2015","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"key":"10.1016\/j.molimm.2018.05.011_bib0140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2017.05.024","article-title":"Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease","volume":"67","author":"Weng","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molmed.2010.10.007","article-title":"NKT cell costimulation: experimental progress and therapeutic promise","volume":"17","author":"van den Heuvel","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molimm.2018.05.011_bib0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.181.2.907","article-title":"Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway","volume":"181","author":"Williams","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0155","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.149.2.735","article-title":"A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily","volume":"149","author":"Zhou","year":"1992","journal-title":"J. Immunol. (Baltim., Md. : 1950)"},{"key":"10.1016\/j.molimm.2018.05.011_bib0160","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/3965","article-title":"Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells","volume":"4","author":"Desbarats","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2018.05.011_bib0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/intimm\/dxp028","article-title":"FasL cross-linking inhibits activation of human peripheral t cells","volume":"21","author":"Paulsen","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0170","doi-asserted-by":"crossref","first-page":"e1110","DOI":"10.1038\/cddis.2014.83","article-title":"FAS system deregulation in T-cell lymphoblastic lymphoma","volume":"5","author":"Villa-Morales","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molimm.2018.05.011_bib0175","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1158\/0008-5472.CAN-06-4006","article-title":"A role for the Fas\/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas","volume":"67","author":"Villa-Morales","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2018.05.011_bib0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2133.2000.03656.x","article-title":"Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL","volume":"143","author":"Zoi-Toli","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0185","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"Parekh","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2018.05.011_bib0190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/intimm\/dxq444","article-title":"Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation","volume":"22","author":"Iyoda","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0195","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.174.8.4639","article-title":"Signals from CD28 induce stable epigenetic modification of the IL-2 promoter","volume":"174","author":"Thomas","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.05.011_bib0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00262-013-1509-4","article-title":"The immunoregulatory role of type I and type II NKT cells in cancer and other diseases","volume":"63","author":"Terabe","year":"2014","journal-title":"Cancer Immunol. Immunother. : CII"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018301561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018301561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T16:44:23Z","timestamp":1751647463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018301561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"alternative-id":["S0161589018301561"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.05.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fas\/FasL interaction mediates imbalanced cytokine\/cytotoxicity responses of iNKT cells against Jurkat cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}